Medicaid Expansion Boosts Rx Fills 79% For High-Cost Patients – RAND Study
Executive Summary
Diabetics who were previously uninsured boosted their rate of drug use more than individuals with other chronic diseases once they obtained coverage in 2014, study finds.
You may also be interested in...
Medicaid Driving New Retail Scripts – IMS
Medicaid prescriptions jumped 25.4% in the 27 states, plus D.C., that expanded coverage under ACA.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.